The use of cardiac magnetic resonance imaging to determine the aetiology of left ventricular disease and cardiomyopathy

Heart

Volumn 94, Issue 4, 2008, Pages 510-518

  Germans, Tjeerd ^a,b   Van Rossum, Albert C ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOIDOSIS; CHAGAS DISEASE; CONSTRICTIVE PERICARDITIS; DIAGNOSTIC ACCURACY; ELECTROCARDIOGRAM; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; GENOTYPE; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPEREOSINOPHILIC SYNDROME; HYPERTROPHIC CARDIOMYOPATHY; IRON OVERLOAD; MYOCARDITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RESTRICTIVE CARDIOMYOPATHY; REVIEW; SARCOIDOSIS;

CARDIOMYOPATHIES; CARDIOMYOPATHY, DILATED; CARDIOMYOPATHY, HYPERTROPHIC; CARDIOMYOPATHY, RESTRICTIVE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 41149147063     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2007.122770     Document Type: Review

References (21)

1. Alfakih K, Plein S, Thiele H, et al. Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady-state free precession imaging seguences. J Magn Reson Imaging 2003;17:323-9. ▶ This study provides an overview of a standard long and short axes scanning protocol of the left and right ventricle, and provides normal values of volumes and mass, differentiating between males and females.
2. Petersen SE, Selvanayagam JB, Francis JM, et al. Differentiation of athlete's heart from pathological forms of cardiac hypertrophy by means of geometric indices derived from cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2005;7:551-8.
3. Rickers C, Wilke NM, Jerosch-Herold M, et al. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation 2005;112:855-61.
4. Teraoka K, Hirano M, Ookubo H, et al. Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy. Magn Reson Imaging 2004;22:155-61.
5. Moon JC, McKenna WJ, McCrohon JA, et al. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 2003;41:1561-7. ▶ The first study demonstrating that the number of risk factors for sudden death in hypertrophic cardiomyopathy is related to the extent of hyperenhancement.
6. Germans T, Wilde AA, Dijkmans PA, et al. Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations. J Am Coll Cardiol 2006;48:2518-23.
7. Maceira AM, Joshi J, Prasad SK, et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 2005;111:186-93. ▶ The study shows that amyloidosis patients exhibit a typical pattern of hyperenhancement which in clinical practice has proven to accurately discriminate cardiac involvement in amyloidosis from other forms of hypertrophic and restrictive cardiomyopathies.
8. Moon JC, Sachdev B, Elkington AG, et al. Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium. Eur Heart J 2003;24:2151-5.
9. Anderson LJ, Holden S, Davis R, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001;22:2171-9. ▶ A study describing a method to quantify non-invasively the extent of iron overload in the heart. Data from this study will help clinicians to timely initiate treatment in iron overload patients before the development of heart failure, by measuring T2* values of the myocardium.
10. Mavrogeni SI, Markussis V, Kaklamanis L, et al. A comparison of magnetic resonance imaging and cardiac biopsy in the evaluation of heart iron overload in patients with beta-thalassemia major. Eur J Haematol 2005;75:241-7.
11. McCrohon JA, Moon JC, Prasad SK, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003;108:54-9.
12. Assomull RG, Prasad SK, Lyne J, et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006;48:1977-85.
13. Mahrholdt H, Klem I, Sechtem U. Cardiovascular MRI for detection of myocardial viability and ischaemia. Heart 2007;93:122-9.
14. Rochitte CE, Oliveira PF, Andrade JM, et al. Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas' disease: a marker of disease severity. J Am Coll Cardiol 2005;46:1553-8.
15. Smedema JP, Snoep G, van Kroonenburgh MP, et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 2005;45:1683- 90. ▶ The first study strongly suggesting that contrast enhanced CMR can rule out cardiac involvement in sarcoidosis. However, prognostic data are still awaited.
16. Friedrich MG, Strohm O, Schulz-Menger J, et al. Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation 1998;97:1802-9.
17. Wagner A, Schulz-Menger J, Dietz R, et al. Long-term follow-up of patients with acute myocarditis by magnetic resonance imaging. MAGMA 2003;16:17-20.
18. Mahrholdt H, Goedecke C, Wagner A, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 2004;109:1250-8.
19. Mahrholdt H, Wagner A, Judd RM, et al. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 2005;26:1461-74. ▶ In depth review on the use of contrast enhanced CMR in differentiating ischaemic from non-ischaemic cardiomyopathy and the histological background of the various types of hyperenhancement described.
20. Sen-Chowdhry S, Prasad SK, Syrris P, et al. Cardiovascular magnetic resonance in arrhythmogenic right ventricular cardiomyopathy revisited: comparison with task force criteria and genotype. J Am Coll Cardiol 2006;48:2132-40. ▶ A study including genotyped ARVC patients that demonstrates the diagnostic accuracy of CMR and its limitations in diagnosing ARVC.
21. Petersen SE, Selvanayagam JB, Wiesmann F, et al. Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol 2005;46:101-5. ▶ The first study fulfilling the need of cardiologists and radiologists involved in CMR imaging for tailored diagnostic criteria of isolated non-compaction cardiomyopathy.